We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$17B
AUM Growth
+$1.75B
Cap. Flow
+$808M
Cap. Flow %
4.76%
Top 10 Hldgs %
16.45%
Holding
2,292
New
159
Increased
1,096
Reduced
891
Closed
119
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCK icon
901
Crown Holdings
CCK
$13.1B
$2.92M 0.02%
28,531
+20,516
+256% +$2.16M
DMF
902
DELISTED
BNY Mellon Municipal Income
DMF
$2.91M 0.02%
313,020
-73,708
-19% -$669K
ENB icon
903
Enbridge
ENB
$113B
$2.91M 0.02%
72,609
+5,583
+8% +$216K
THO icon
904
Thor Industries
THO
$4.08B
$2.91M 0.02%
25,718
+7,194
+39% +$915K
ALLY icon
905
Ally Financial
ALLY
$13.3B
$2.89M 0.02%
57,979
+50,357
+661% +$2.58M
IT icon
906
Gartner
IT
$11.9B
$2.87M 0.02%
11,860
+2,733
+30% +$598K
GNTX icon
907
Gentex
GNTX
$5.08B
$2.87M 0.02%
86,698
-71,123
-45% -$2.47M
VRTV
908
DELISTED
VERITIV CORPORATION
VRTV
$2.86M 0.02%
46,614
+18,738
+67% +$979K
MUI
909
DELISTED
BlackRock Municipal Income Fund, Inc.
MUI
$2.86M 0.02%
182,766
-3,693
-2% -$56.8K
VTA
910
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$2.85M 0.02%
240,505
+30,640
+15% +$356K
TFX icon
911
Teleflex
TFX
$6.03B
$2.85M 0.02%
7,093
-3,578
-34% -$1.47M
TWST icon
912
Twist Bioscience
TWST
$7.14B
$2.85M 0.02%
21,354
+1,197
+6% +$139K
GLO
913
Clough Global Opportunities Fund
GLO
$257M
$2.84M 0.02%
235,019
-6,090
-3% -$76.5K
SPTN
914
DELISTED
SpartanNash
SPTN
$2.84M 0.02%
147,187
+51,680
+54% +$1.03M
ROL icon
915
Rollins
ROL
$18B
$2.83M 0.02%
82,885
+11,283
+16% +$394K
TRMB icon
916
Trimble
TRMB
$13.7B
$2.83M 0.02%
34,625
+6,479
+23% +$515K
AZN icon
917
AstraZeneca
AZN
$249B
$2.83M 0.02%
23,588
+863
+4% +$94.7K
SCCO icon
918
Southern Copper
SCCO
$167B
$2.82M 0.02%
47,297
-18,379
-28% -$1.19M
VMC icon
919
Vulcan Materials
VMC
$37B
$2.81M 0.02%
16,141
+3,674
+29% +$657K
PII icon
920
Polaris
PII
$4.03B
$2.79M 0.02%
20,386
+12,689
+165% +$1.72M
BBIO icon
921
BridgeBio Pharma
BBIO
$16.2B
$2.79M 0.02%
+45,749
New +$2.61M
WEN icon
922
Wendy's
WEN
$1.42B
$2.79M 0.02%
118,947
-17,308
-13% -$397K
LNC icon
923
Lincoln National
LNC
$8.87B
$2.77M 0.02%
44,164
-9,121
-17% -$602K
MFM
924
Aberdeen Municipal Income Fund
MFM
$224M
$2.76M 0.02%
386,489
+58,645
+18% +$413K
HUBB icon
925
Hubbell
HUBB
$27.3B
$2.75M 0.02%
14,738
-3,313
-18% -$626K

Similar funds

Guggenheim Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Guggenheim Capital held 2,292 positions worth $17B, up 12% from $15.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Guggenheim Capital deployed $808M of net new capital in Q2 2021, opening 159 new positions and adding to 1,096 existing holdings. Its largest new stake was KKR Acquisition Holdings I Corp.: 15,278,818 shares worth $150M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was RXR Acquisition Corp. Units, an estimated $32.6M trimmed.

  • Guggenheim Capital's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 15,278,818 shares worth $150M.
  • Guggenheim Capital added most to Apple in Q2 2021, an estimated $49.1M increase.
  • Guggenheim Capital's biggest Q2 2021 reduction was RXR Acquisition Corp. Units, cutting an estimated $32.6M.
  • Guggenheim Capital fully exited KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant in Q2 2021, selling an estimated $153M.
  • Guggenheim Capital's ten largest holdings make up 16% of its $17B portfolio in Q2 2021.
  • Guggenheim Capital opened 159 new positions and closed 119 in Q2 2021.
  • Guggenheim Capital's portfolio value rose 12% quarter-over-quarter to $17B.

Based on Guggenheim Capital's 13F filing for Q2 2021, filed 13 Aug 2021.